Ardent Health lifts 2026 outlook as margin discipline offsets mixed volume trends
Ardent Health entered the third quarter with a clearer operating rhythm and came out of it with a better earnings picture. Expense control, especially on labor, combined with steadier demand across the front end of the care pipeline to push the for-profit system toward higher adjusted EBITDA expectations for 2026.
The quarter did not erase every pressure point. Surgical volumes remained uneven, exchange-related admissions stayed soft, and management continued to describe a healthcare environment shaped by payer churn and policy uncertainty. Even so, the underlying financial trajectory improved enough to prompt an upward revision to guidance, with revenue still expected to land toward the lower end of the company’s prior range.
Labor savings and Project IMPACT moved from theory to operating results
Ardent’s internal turnaround effort, Project IMPACT, sat at the center of the quarter’s performance. The program, designed to improve margins, performance, agility and care transformation, remains on track to deliver at least $70 million in benefit for 2026. In practical terms, that showed up in a 4% year-over-year decline in salaries, wages and benefits expense during the quarter, helped in part by lower contract labor spending.
The labor reset matters because staffing costs have been one of the most stubborn inflation points in hospital finance since the pandemic era. A reduction in contract labor, paired with tighter workforce deployment, improves operating leverage quickly when patient volumes are stable or rising. Ardent reported that salaries, wages and benefits fell to 39.9% of revenue, a 300-basis-point improvement from the prior year, while contract labor dropped from 3.5% of total salaries, wages and benefits to 2%.
One sentence captures the quarter’s operational turn: the system is spending less to deliver the same care.
Professional fee expense growth also slowed, from 12.9% in the first quarter of 2026 to 7.4% in the third quarter, with further moderation expected in the fourth quarter. Supply growth stayed modest at 2.6%, reinforcing the sense that the company is squeezing more efficiency out of a still-complex delivery model. These are not dramatic cuts for their own sake; they are the kind of incremental gains that preserve cash flow while protecting access to services.
Demand held up at the top of the funnel even as exchange volume softened
Ardent’s leadership repeatedly pointed to strength in what it calls the “top of the funnel,” meaning urgent care visits, physician encounters and other entry points that can feed downstream utilization. Admissions grew 0.1% year over year, while adjusted admissions increased 2.9%, a better result than the second quarter and a sign that demand has not slipped off entirely.
Net patient service revenue per adjusted admission rose 0.7% compared with the third quarter of 2025. That combination of slightly firmer utilization and improved yield helped cushion the effect of weaker surgical activity. Inpatient surgeries declined 5% from the year-earlier period, and outpatient surgeries fell 0.6%. Chief Financial Officer Alfred Lumsdaine attributed about half of those declines to an intentional rationalization of lower-margin service lines in selected locations.
That move is financially rational, but it also reveals the tension at the heart of modern hospital strategy: not every procedure produces the same return, and not every market needs the same footprint. By pruning lower-margin service lines, Ardent is betting that fewer, better-aligned procedures can improve margin without undermining the broader care network.
Exchange admissions dropped 7%, with self-pay volume rising in parallel, a pattern similar to the 8% decline in the second quarter. Management described that shift as manageable and already embedded in guidance. The company appears to be absorbing some payer-mix instability without letting it derail the full-year plan.
Portfolio pruning and capital discipline are now part of the growth story
Ardent is also rethinking where it wants to own and operate assets over the long term. Leadership said the company is reviewing its portfolio to determine which businesses fit its strategic priorities, a process that already contributed to September’s divestiture from a joint venture with the University of Kansas Health System. The capital strategy is not passive. It is meant to direct investment toward organic growth in mid-sized urban markets while preserving a disciplined stance on acquisitions and joint ventures.
CEO Dave Caspar framed the quarter as progress against a defined set of priorities: more consistent financial results, higher EBITDA, more effective capital deployment and stronger execution on commitments. The message from the call was that portfolio management and operational execution now move together rather than separately. Asset selection, labor efficiency and care-volume conversion are being treated as one operating system.
There is a logic to that sequencing. Hospitals with broad footprints often carry assets that no longer fit their growth profile or margin goals, especially when reimbursement pressure and labor volatility persist. Selling or exiting those positions can free up capital for markets with stronger growth potential and more controllable economics.
Guidance rises even as revenue stays near the low end of the range
The third quarter led Ardent to raise its 2026 earnings outlook. Revenue is still expected to come in on the lower end of the $6.4 billion to $6.7 billion range, but adjusted EBITDA guidance moved up 1.5% at the midpoint. For investors, that is the more important signal. Revenue growth matters, but earnings power tells the fuller story when hospitals are navigating labor normalization, volume wobble and payer complexity at the same time.
The company did not provide specific 2027 targets, but management pointed to familiar headwinds: Medicaid work requirements, marketplace plan attrition and broader coverage instability. At the same time, executives cited tailwinds from Project IMPACT and the recently finalized outpatient payment rule. Those forces will not all move in the same direction, and the margin picture will likely depend on how well Ardent continues to convert front-end demand into downstream utilization without reintroducing friction.
For a health system with 30 acute care hospitals and more than 280 care sites, that conversion work is not abstract. A small gain in access, scheduling or referral flow can compound across a large network and turn into real revenue retention.
Ardent reported $1.62 billion in third-quarter revenue, up 3.1% year over year, along with $45 million in net income and $130 million in adjusted EBITDA. In 2025, the company increased revenue by 6% to $6.3 billion and lifted adjusted EBITDA to $545 million. The quarter suggests the company is trying to build on that base with a narrower, more selective operating model. The remaining question is how far that model can stretch if exchange churn, surgical mix pressure and policy changes all intensify at once.